Xiafei Wei
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Trajectory-Based Integration of Biomarker Dynamics and Clinical Features for Prognostic Prediction in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Journal: Journal of hepatocellular carcinoma
Published: May 06, 2026
Albendazole Suppresses SARS-CoV-2 Replication by Enhancing HERC5-Mediated ISGylation of Nucleocapsid Protein.
Journal: Journal of medical virology
Published: August 12, 2025
Tissue Factor Pathway Inhibitor 2 Enhances Hepatocellular Carcinoma Chemosensitivity by Activating CCAR2-GADD45A-Mediated DNA Damage Repair.
Journal: International journal of biological sciences
Published: January 26, 2025
E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5.
Journal: Journal of medical virology
Published: June 30, 2024
Lung-Targeted Lipid Nanoparticle-Delivered siUSP33 Attenuates SARS-CoV-2 Replication and Virulence by Promoting Envelope Degradation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2024
The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
Journal: mBio
Published: January 26, 2024
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.
Journal: Acta pharmaceutica Sinica. B
Published: December 09, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026